Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

258.00
-2.1000-0.81%
Pre-market: 258.000.00000.00%07:29 EDT
Volume:1.43M
Turnover:366.38M
Market Cap:34.42B
PE:45.91
High:261.98
Open:257.07
Low:253.28
Close:260.10
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.69
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:25.42
PE(LYR):110.73

Loading ...

Alnylam Pharmaceuticals Price Target Raised to $260.00/Share from $230.00 by Jefferies

Dow Jones
·
Sep 08

Movement Alert|Alnylam Pharmaceuticals Falls 5.3% in Pre-Market Trading, Trading at $251.34

Market Focus
·
Sep 08

Alnylam price target raised to $260 from $230 at Jefferies

TIPRANKS
·
Sep 08

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement

TradingKey
·
Sep 03

Movement Alert|Alnylam Pharmaceuticals Rises 5.22% in Regular Trading, Competitor Data Setback and Analyst Optimism on Next-Gen Pipeline

Market Focus
·
Sep 02

Alnylam to Webcast Investor Conference Presentations in September

Reuters
·
Sep 02

Alnylam Pharmaceuticals Price Target Maintained with a $455.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 02

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live
·
Aug 31

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Reuters
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Piper Sandler Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

Stifel Nicolaus Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

Alnylam announces new data at ESC Congress on AMVUTTRA

TIPRANKS
·
Aug 31

Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment

Reuters
·
Aug 28

Movement Alert|Alnylam Pharmaceuticals Falls 5.65% in Pre-Market Trading, Trading at $223.2

Market Focus
·
Aug 28

Alnylam (ALNY) Stock May Look Rich On Earnings Despite Weaker Price Action

Simply Wall St.
·
Aug 25

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

TIPRANKS
·
Aug 24